25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SomnoMed Ltd
Buy, Hold or Sell?

Let's analyze Somnomed together

I guess you are interested in SomnoMed Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SomnoMed Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about SomnoMed Ltd

I send you an email if I find something interesting about SomnoMed Ltd.

1. Quick Overview

1.1. Quick analysis of Somnomed (30 sec.)










1.2. What can you expect buying and holding a share of Somnomed? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.10
Expected worth in 1 year
A$0.00
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.10
Return On Investment
-22.9%

For what price can you sell your share?

Current Price per Share
A$0.44
Expected price per share
A$0.4 - A$0.52
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Somnomed (5 min.)




Live pricePrice per Share (EOD)
A$0.44
Intrinsic Value Per Share
A$-0.97 - A$-0.12
Total Value Per Share
A$-0.87 - A$-0.01

2.2. Growth of Somnomed (5 min.)




Is Somnomed growing?

Current yearPrevious yearGrowGrow %
How rich?$15.1m$18.8m-$3.6m-24.0%

How much money is Somnomed making?

Current yearPrevious yearGrowGrow %
Making money-$5.4m-$3m-$2.4m-44.5%
Net Profit Margin-9.6%-6.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Somnomed (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#211 / 328

Most Revenue
#93 / 328

Most Profit
#224 / 328

Most Efficient
#152 / 328
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Somnomed?

Welcome investor! Somnomed's management wants to use your money to grow the business. In return you get a share of Somnomed.

First you should know what it really means to hold a share of Somnomed. And how you can make/lose money.

Speculation

The Price per Share of Somnomed is A$0.435. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Somnomed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Somnomed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.10. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Somnomed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.03-5.8%-0.03-5.8%-0.01-3.2%-0.02-4.5%-0.01-3.0%
Usd Book Value Change Per Share-0.02-3.9%-0.02-3.9%-0.01-3.1%-0.01-1.5%0.000.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.023.6%0.011.8%
Usd Total Gains Per Share-0.02-3.9%-0.02-3.9%-0.01-3.1%0.012.1%0.012.6%
Usd Price Per Share0.62-0.62-0.78-0.88-1.16-
Price to Earnings Ratio-24.67--24.67--56.36--140.25-436.23-
Price-to-Total Gains Ratio-36.65--36.65--57.23--77.03--11.62-
Price to Book Ratio8.81-8.81-9.00-10.76-14.48-
Price-to-Total Gains Ratio-36.65--36.65--57.23--77.03--11.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2943645
Number of shares3397
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share-0.020.01
Gains per Quarter (3397 shares)-57.2831.25
Gains per Year (3397 shares)-229.12125.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-229-239213-88115
20-458-468426-176240
30-687-697640-265365
40-916-926853-353490
50-1146-11551066-441615
60-1375-13841279-529740
70-1604-16131492-617865
80-1833-18421706-706990
90-2062-20711919-7941115
100-2291-23002132-8821240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.07.00.030.0%7.012.01.035.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%12.08.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%2.00.08.020.0%2.00.018.010.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%12.08.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of SomnoMed Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.025-0.0250%-0.020-19%-0.010-62%0.005-597%
Book Value Per Share--0.1040.1040%0.129-19%0.124-16%0.122-15%
Current Ratio--1.4981.4980%1.275+17%1.656-10%2.208-32%
Debt To Asset Ratio--0.6410.6410%0.522+23%0.506+27%0.382+68%
Debt To Equity Ratio--1.7891.7890%1.091+64%1.080+66%0.714+151%
Dividend Per Share----0%-0%0.023-100%0.012-100%
Eps---0.037-0.0370%-0.021-45%-0.029-22%-0.019-48%
Free Cash Flow Per Share---0.048-0.0480%-0.032-33%-0.022-54%-0.020-59%
Free Cash Flow To Equity Per Share---0.017-0.0170%-0.022+31%0.000-98%0.005-434%
Gross Profit Margin--4.0624.0620%5.449-25%83.875-95%31.543-87%
Intrinsic Value_10Y_max---0.118--------
Intrinsic Value_10Y_min---0.970--------
Intrinsic Value_1Y_max---0.018--------
Intrinsic Value_1Y_min---0.046--------
Intrinsic Value_3Y_max---0.049--------
Intrinsic Value_3Y_min---0.184--------
Intrinsic Value_5Y_max---0.075--------
Intrinsic Value_5Y_min---0.370--------
Market Cap94006980.000-110%197371436.400197371436.4000%250080177.600-21%281891275.200-30%370203809.400-47%
Net Profit Margin---0.096-0.0960%-0.061-36%-0.039-59%-0.019-81%
Operating Margin---0.049-0.0490%-0.057+17%-0.025-49%-0.015-69%
Operating Ratio--1.0491.0490%1.057-1%1.024+2%1.013+4%
Pb Ratio4.196-110%8.8108.8100%8.999-2%10.756-18%14.480-39%
Pe Ratio-11.752+52%-24.674-24.6740%-56.363+128%-140.252+468%436.228-106%
Price Per Share0.435-110%0.9130.9130%1.157-21%1.304-30%1.713-47%
Price To Free Cash Flow Ratio-9.132+52%-19.172-19.1720%-36.083+88%-65.108+240%220.342-109%
Price To Total Gains Ratio-17.458+52%-36.653-36.6530%-57.226+56%-77.031+110%-11.622-68%
Quick Ratio--1.1431.1430%1.045+9%1.371-17%1.816-37%
Return On Assets---0.128-0.1280%-0.076-40%-0.049-62%-0.023-82%
Return On Equity---0.357-0.3570%-0.160-55%-0.118-67%-0.056-84%
Total Gains Per Share---0.025-0.0250%-0.020-19%0.014-283%0.017-250%
Usd Book Value--15160363.18615160363.1860%18804298.625-19%18136225.873-16%17898363.928-15%
Usd Book Value Change Per Share---0.017-0.0170%-0.014-19%-0.006-62%0.003-597%
Usd Book Value Per Share--0.0700.0700%0.087-19%0.084-16%0.083-15%
Usd Dividend Per Share----0%-0%0.016-100%0.008-100%
Usd Eps---0.025-0.0250%-0.014-45%-0.020-22%-0.013-48%
Usd Free Cash Flow---6966481.686-6966481.6860%-4689966.118-33%-3185104.688-54%-2870088.725-59%
Usd Free Cash Flow Per Share---0.032-0.0320%-0.022-33%-0.015-54%-0.013-59%
Usd Free Cash Flow To Equity Per Share---0.012-0.0120%-0.015+31%0.000-98%0.003-434%
Usd Market Cap63614523.366-110%133561251.012133561251.0120%169229256.182-21%190755825.928-30%250516917.821-47%
Usd Price Per Share0.294-110%0.6180.6180%0.783-21%0.883-30%1.159-47%
Usd Profit---5412953.075-5412953.0750%-3002495.569-45%-2001265.678-63%-991091.843-82%
Usd Revenue--56583058.17956583058.1790%49115158.710+15%45351249.098+25%36921324.082+53%
Usd Total Gains Per Share---0.017-0.0170%-0.014-19%0.009-283%0.011-250%
 EOD+3 -5MRQTTM+0 -0YOY+10 -245Y+4 -3210Y+5 -31

3.3 Fundamental Score

Let's check the fundamental score of SomnoMed Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.752
Price to Book Ratio (EOD)Between0-14.196
Net Profit Margin (MRQ)Greater than0-0.096
Operating Margin (MRQ)Greater than0-0.049
Quick Ratio (MRQ)Greater than11.143
Current Ratio (MRQ)Greater than11.498
Debt to Asset Ratio (MRQ)Less than10.641
Debt to Equity Ratio (MRQ)Less than11.789
Return on Equity (MRQ)Greater than0.15-0.357
Return on Assets (MRQ)Greater than0.05-0.128
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of SomnoMed Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.709
Ma 20Greater thanMa 500.372
Ma 50Greater thanMa 1000.348
Ma 100Greater thanMa 2000.293
OpenGreater thanClose0.430
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About SomnoMed Ltd

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Fundamental data was last updated by Penke on 2024-08-13 19:27:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Somnomed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Net Profit Margin of -9.6% means that $-0.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SomnoMed Ltd:

  • The MRQ is -9.6%. The company is making a loss. -1
  • The TTM is -9.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-9.6%0.0%
TTM-9.6%YOY-6.1%-3.5%
TTM-9.6%5Y-3.9%-5.6%
5Y-3.9%10Y-1.9%-2.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-11.6%+2.0%
TTM-9.6%-16.1%+6.5%
YOY-6.1%-16.0%+9.9%
5Y-3.9%-18.9%+15.0%
10Y-1.9%-24.6%+22.7%
4.3.1.2. Return on Assets

Shows how efficient Somnomed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • -12.8% Return on Assets means that Somnomed generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SomnoMed Ltd:

  • The MRQ is -12.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-12.8%0.0%
TTM-12.8%YOY-7.6%-5.2%
TTM-12.8%5Y-4.9%-7.9%
5Y-4.9%10Y-2.3%-2.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-3.2%-9.6%
TTM-12.8%-3.9%-8.9%
YOY-7.6%-3.7%-3.9%
5Y-4.9%-3.4%-1.5%
10Y-2.3%-4.0%+1.7%
4.3.1.3. Return on Equity

Shows how efficient Somnomed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • -35.7% Return on Equity means Somnomed generated $-0.36 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SomnoMed Ltd:

  • The MRQ is -35.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -35.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-35.7%TTM-35.7%0.0%
TTM-35.7%YOY-16.0%-19.7%
TTM-35.7%5Y-11.8%-23.9%
5Y-11.8%10Y-5.6%-6.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.7%-3.9%-31.8%
TTM-35.7%-4.6%-31.1%
YOY-16.0%-4.2%-11.8%
5Y-11.8%-5.0%-6.8%
10Y-5.6%-5.6%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of SomnoMed Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Somnomed is operating .

  • Measures how much profit Somnomed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • An Operating Margin of -4.9% means the company generated $-0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SomnoMed Ltd:

  • The MRQ is -4.9%. The company is operating very inefficient. -2
  • The TTM is -4.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4.9%TTM-4.9%0.0%
TTM-4.9%YOY-5.7%+0.8%
TTM-4.9%5Y-2.5%-2.4%
5Y-2.5%10Y-1.5%-1.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.9%-7.8%+2.9%
TTM-4.9%-15.9%+11.0%
YOY-5.7%-10.8%+5.1%
5Y-2.5%-17.7%+15.2%
10Y-1.5%-22.4%+20.9%
4.3.2.2. Operating Ratio

Measures how efficient Somnomed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are $1.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.049. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.049. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.0490.000
TTM1.049YOY1.057-0.008
TTM1.0495Y1.024+0.025
5Y1.02410Y1.013+0.011
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0491.475-0.426
TTM1.0491.402-0.353
YOY1.0571.425-0.368
5Y1.0241.418-0.394
10Y1.0131.402-0.389
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of SomnoMed Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Somnomed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.50 means the company has $1.50 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.498. The company is just able to pay all its short-term debts.
  • The TTM is 1.498. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.498TTM1.4980.000
TTM1.498YOY1.275+0.223
TTM1.4985Y1.656-0.158
5Y1.65610Y2.208-0.552
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4982.547-1.049
TTM1.4982.618-1.120
YOY1.2753.076-1.801
5Y1.6563.521-1.865
10Y2.2083.594-1.386
4.4.3.2. Quick Ratio

Measures if Somnomed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Quick Ratio of 1.14 means the company can pay off $1.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.143. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.143. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.143TTM1.1430.000
TTM1.143YOY1.045+0.098
TTM1.1435Y1.371-0.228
5Y1.37110Y1.816-0.445
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1431.099+0.044
TTM1.1431.420-0.277
YOY1.0451.960-0.915
5Y1.3712.518-1.147
10Y1.8162.604-0.788
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of SomnoMed Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Somnomed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Somnomed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.64 means that Somnomed assets are financed with 64.1% credit (debt) and the remaining percentage (100% - 64.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SomnoMed Ltd:

  • The MRQ is 0.641. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.641. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.641TTM0.6410.000
TTM0.641YOY0.522+0.120
TTM0.6415Y0.506+0.136
5Y0.50610Y0.382+0.124
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6410.412+0.229
TTM0.6410.412+0.229
YOY0.5220.355+0.167
5Y0.5060.440+0.066
10Y0.3820.462-0.080
4.5.4.2. Debt to Equity Ratio

Measures if Somnomed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 178.9% means that company has $1.79 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.789. The company is just able to pay all its debts with equity.
  • The TTM is 1.789. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.789TTM1.7890.000
TTM1.789YOY1.091+0.699
TTM1.7895Y1.080+0.709
5Y1.08010Y0.714+0.366
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7890.587+1.202
TTM1.7890.595+1.194
YOY1.0910.523+0.568
5Y1.0800.618+0.462
10Y0.7140.688+0.026
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Somnomed generates.

  • Above 15 is considered overpriced but always compare Somnomed to the Medical Devices industry mean.
  • A PE ratio of -24.67 means the investor is paying $-24.67 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SomnoMed Ltd:

  • The EOD is -11.752. Based on the earnings, the company is expensive. -2
  • The MRQ is -24.674. Based on the earnings, the company is expensive. -2
  • The TTM is -24.674. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.752MRQ-24.674+12.922
MRQ-24.674TTM-24.6740.000
TTM-24.674YOY-56.363+31.688
TTM-24.6745Y-140.252+115.578
5Y-140.25210Y436.228-576.480
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-11.752-1.009-10.743
MRQ-24.674-1.423-23.251
TTM-24.674-2.130-22.544
YOY-56.363-2.109-54.254
5Y-140.252-2.241-138.011
10Y436.228-2.014+438.242
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SomnoMed Ltd:

  • The EOD is -9.132. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -19.172. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.172. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.132MRQ-19.172+10.040
MRQ-19.172TTM-19.1720.000
TTM-19.172YOY-36.083+16.911
TTM-19.1725Y-65.108+45.936
5Y-65.10810Y220.342-285.450
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-9.132-1.710-7.422
MRQ-19.172-2.470-16.702
TTM-19.172-1.826-17.346
YOY-36.083-5.914-30.169
5Y-65.108-4.813-60.295
10Y220.342-5.704+226.046
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Somnomed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 8.81 means the investor is paying $8.81 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of SomnoMed Ltd:

  • The EOD is 4.196. Based on the equity, the company is fair priced.
  • The MRQ is 8.810. Based on the equity, the company is overpriced. -1
  • The TTM is 8.810. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.196MRQ8.810-4.614
MRQ8.810TTM8.8100.000
TTM8.810YOY8.999-0.190
TTM8.8105Y10.756-1.946
5Y10.75610Y14.480-3.725
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD4.1962.074+2.122
MRQ8.8102.116+6.694
TTM8.8102.326+6.484
YOY8.9992.973+6.026
5Y10.7564.148+6.608
10Y14.4804.774+9.706
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of SomnoMed Ltd.

4.8.2. Funds holding SomnoMed Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-01-31Fidelity International Small Cap Fund4.71-3898596--
2021-01-31DFA Asia Pacific Small Company Series0.029999999-25160--
Total 4.7399999990392375600.0%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Net Debt  -4,102-10,543-14,6442,442-12,2028,568-3,63415,18811,554



5.2. Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets62,491
Total Liabilities40,088
Total Stockholder Equity22,403
 As reported
Total Liabilities 40,088
Total Stockholder Equity+ 22,403
Total Assets = 62,491

Assets

Total Assets62,491
Total Current Assets27,496
Long-term Assets34,996
Total Current Assets
Cash And Cash Equivalents 11,956
Net Receivables 9,029
Inventory 4,100
Other Current Assets 2,410
Total Current Assets  (as reported)27,496
Total Current Assets  (calculated)27,496
+/-0
Long-term Assets
Property Plant Equipment 12,730
Goodwill 6,491
Intangible Assets 18,974
Long-term Assets Other -6,491
Long-term Assets  (as reported)34,996
Long-term Assets  (calculated)31,704
+/- 3,292

Liabilities & Shareholders' Equity

Total Current Liabilities18,360
Long-term Liabilities21,728
Total Stockholder Equity22,403
Total Current Liabilities
Short-term Debt 2,569
Short Long Term Debt 313
Accounts payable 11,996
Other Current Liabilities 3,561
Total Current Liabilities  (as reported)18,360
Total Current Liabilities  (calculated)18,439
+/- 80
Long-term Liabilities
Long term Debt Total 20,941
Capital Lease Obligations Min Short Term Debt4,272
Other Liabilities 787
Long-term Liabilities  (as reported)21,728
Long-term Liabilities  (calculated)26,001
+/- 4,272
Total Stockholder Equity
Common Stock74,271
Retained Earnings -62,295
Accumulated Other Comprehensive Income 10,427
Total Stockholder Equity (as reported)22,403
Total Stockholder Equity (calculated)22,403
+/-0
Other
Capital Stock74,271
Cash And Equivalents11,956
Cash and Short Term Investments 11,956
Common Stock Shares Outstanding 82,149
Current Deferred Revenue233
Liabilities and Stockholders Equity 62,491
Net Debt 11,554
Net Invested Capital 39,073
Net Tangible Assets 13,098
Net Working Capital 9,136
Property Plant and Equipment Gross 23,935
Short Long Term Debt Total 23,511



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-30
> Total Assets 
118
625
7,918
4,069
4,699
7,004
6,038
7,834
8,732
12,312
18,302
19,143
27,751
40,427
41,212
45,698
34,751
61,693
56,166
58,094
62,491
62,49158,09456,16661,69334,75145,69841,21240,42727,75119,14318,30212,3128,7327,8346,0387,0044,6994,0697,918625118
   > Total Current Assets 
0
78
6,768
2,645
3,594
6,212
5,519
6,074
6,328
7,779
9,459
9,405
16,778
27,170
26,355
28,968
20,158
40,235
34,127
30,315
27,496
27,49630,31534,12740,23520,15828,96826,35527,17016,7789,4059,4597,7796,3286,0745,5196,2123,5942,6456,768780
       Cash And Cash Equivalents 
107
51
6,636
2,310
3,205
5,433
4,009
4,294
3,949
3,538
4,221
2,945
8,306
17,632
14,210
13,383
7,697
30,174
21,110
15,644
11,956
11,95615,64421,11030,1747,69713,38314,21017,6328,3062,9454,2213,5383,9494,2944,0095,4333,2052,3106,63651107
       Short-term Investments 
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000011
       Net Receivables 
0
27
132
317
381
746
1,426
1,584
2,202
3,741
3,917
4,346
5,299
6,059
6,619
10,404
7,117
6,126
8,225
9,202
9,029
9,0299,2028,2256,1267,11710,4046,6196,0595,2994,3463,9173,7412,2021,5841,426746381317132270
       Other Current Assets 
0
0
0
0
0
0
182
54
0
21
466
1,149
1,880
1,788
3,578
3,178
3,441
1,692
2,462
2,380
2,410
2,4102,3802,4621,6923,4413,1783,5781,7881,8801,14946621054182000000
   > Long-term Assets 
0
546
1,150
1,424
1,105
793
519
1,759
2,404
4,532
6,310
7,031
7,738
10,079
11,072
13,433
10,912
21,458
22,040
27,778
34,996
34,99627,77822,04021,45810,91213,43311,07210,0797,7387,0316,3104,5322,4041,7595197931,1051,4241,1505460
       Property Plant Equipment 
0
27
658
985
676
457
235
642
1,140
1,069
1,155
1,251
2,105
3,573
4,491
5,690
3,248
10,239
10,342
9,116
12,730
12,7309,11610,34210,2393,2485,6904,4913,5732,1051,2511,1551,0691,140642235457676985658270
       Goodwill 
0
0
0
0
0
0
0
0
0
1,321
4,856
5,690
5,477
6,238
6,171
6,375
6,407
6,469
6,260
6,038
6,491
6,4916,0386,2606,4696,4076,3756,1716,2385,4775,6904,8561,321000000000
       Intangible Assets 
0
520
491
440
388
336
284
232
328
1,513
76
90
156
268
410
1,367
1,257
7,929
8,581
15,448
18,974
18,97415,4488,5817,9291,2571,36741026815690761,5133282322843363884404915200
       Other Assets 
0
0
0
0
0
0
0
857
999
1,855
2,533
2,707
3,235
3,178
3,785
3,297
3,681
3,589
4,370
9,835
3,252
3,2529,8354,3703,5893,6813,2973,7853,1783,2352,7072,5331,8559998570000000
> Total Liabilities 
3
785
716
835
786
996
1,705
2,183
2,515
3,392
6,729
6,573
6,243
7,739
10,257
12,929
16,931
27,858
24,008
30,305
40,088
40,08830,30524,00827,85816,93112,92910,2577,7396,2436,5736,7293,3922,5152,1831,7059967868357167853
   > Total Current Liabilities 
3
785
461
741
786
996
1,705
2,181
2,509
3,380
4,782
4,736
5,471
7,577
9,949
11,540
16,046
18,780
16,197
23,775
18,360
18,36023,77516,19718,78016,04611,5409,9497,5775,4714,7364,7823,3802,5092,1811,7059967867414617853
       Short-term Debt 
0
0
157
157
92
0
196
5
545
54
0
0
0
20
69
398
3,236
7,284
1,956
6,657
2,569
2,5696,6571,9567,2843,236398692000054545519609215715700
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
123
1,435
3,008
4,953
0
4,877
313
3134,87704,9533,0081,43512300000000000000
       Accounts payable 
0
778
251
446
614
835
1,456
1,868
2,202
2,449
3,077
3,046
3,708
6,065
7,545
8,084
7,828
8,277
10,334
12,593
11,996
11,99612,59310,3348,2777,8288,0847,5456,0653,7083,0463,0772,4492,2021,8681,4568356144462517780
       Other Current Liabilities 
3
7
54
138
80
161
249
133
307
338
1,704
1,690
1,763
1,512
1,997
2,761
4,705
2,928
3,647
4,263
3,561
3,5614,2633,6472,9284,7052,7611,9971,5121,7631,6901,704338307133249161801385473
   > Long-term Liabilities 
0
0
255
94
0
0
0
2
5
12
139
1,837
772
161
308
1,389
885
9,077
7,811
6,530
21,728
21,7286,5307,8119,0778851,3893081617721,83713912520009425500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53
1,037
359
8,246
6,952
5,353
20,941
20,9415,3536,9528,2463591,0375300000000000000
       Other Liabilities 
0
0
0
0
0
0
0
2
5
12
139
1,837
772
161
255
352
526
831
859
1,177
787
7871,1778598315263522551617721,83713912520000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
312
248
116
52
37
110
299
1,254
6,620
9,668
9,6686,6201,254299110375211624831200000000000
> Total Stockholder Equity
115
-160
7,201
3,234
3,913
6,009
4,333
5,651
6,217
8,437
11,402
12,338
21,340
33,128
32,214
36,119
17,820
33,835
32,158
27,788
22,403
22,40327,78832,15833,83517,82036,11932,21433,12821,34012,33811,4028,4376,2175,6514,3336,0093,9133,2347,201-160115
   Retained Earnings -62,295-54,296-49,859-48,666-47,491-27,731-19,140-15,767-15,904-16,501-17,097-18,126-18,651-19,390-20,177-18,358-15,627-12,352-7,709-4,4420
   Accumulated Other Comprehensive Income 
0
-1
-35
676
926
1,096
1,239
1,334
827
1,159
2,398
2,403
3,566
4,372
4,416
6,135
7,685
8,558
7,760
7,813
10,427
10,4277,8137,7608,5587,6856,1354,4164,3723,5662,4032,3981,1598271,3341,2391,096926676-35-10
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue83,616
Cost of Revenue-37,847
Gross Profit45,76945,769
 
Operating Income (+$)
Gross Profit45,769
Operating Expense-49,842
Operating Income-4,073-4,073
 
Operating Expense (+$)
Research Development706
Selling General Administrative13,114
Selling And Marketing Expenses24,491
Operating Expense49,84238,311
 
Net Interest Income (+$)
Interest Income2
Interest Expense-2,627
Other Finance Cost-0
Net Interest Income-2,625
 
Pretax Income (+$)
Operating Income-4,073
Net Interest Income-2,625
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,045-1,100
EBIT - interestExpense = -6,699
-7,177
-5,372
Interest Expense2,627
Earnings Before Interest and Taxes (EBIT)-4,073-4,419
Earnings Before Interest and Taxes (EBITDA)1,044
 
After tax Income (+$)
Income Before Tax-7,045
Tax Provision-822
Net Income From Continuing Ops-7,867-7,867
Net Income-7,999
Net Income Applicable To Common Shares-7,999
 
Non-recurring Events
Discontinued Operations-132
Extraordinary Items-132
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses87,689
Total Other Income/Expenses Net-2,9732,625
 

Technical Analysis of Somnomed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Somnomed. The general trend of Somnomed is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Somnomed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SomnoMed Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.47 < 0.52 < 0.52.

The bearish price targets are: 0.4 > 0.4 > 0.4.

Tweet this
SomnoMed Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SomnoMed Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SomnoMed Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SomnoMed Ltd. The current macd is 0.01519686.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Somnomed price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Somnomed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Somnomed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
SomnoMed Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSomnoMed Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SomnoMed Ltd. The current adx is 31.07.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Somnomed shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
SomnoMed Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SomnoMed Ltd. The current sar is 0.34252523.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
SomnoMed Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SomnoMed Ltd. The current rsi is 67.71. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
SomnoMed Ltd Daily Relative Strength Index (RSI) ChartSomnoMed Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SomnoMed Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Somnomed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
SomnoMed Ltd Daily Stochastic Oscillator ChartSomnoMed Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SomnoMed Ltd. The current cci is 297.49.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
SomnoMed Ltd Daily Commodity Channel Index (CCI) ChartSomnoMed Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SomnoMed Ltd. The current cmo is 43.72.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
SomnoMed Ltd Daily Chande Momentum Oscillator (CMO) ChartSomnoMed Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SomnoMed Ltd. The current willr is -25.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Somnomed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
SomnoMed Ltd Daily Williams %R ChartSomnoMed Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SomnoMed Ltd.

SomnoMed Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SomnoMed Ltd. The current atr is 0.01961244.

SomnoMed Ltd Daily Average True Range (ATR) ChartSomnoMed Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SomnoMed Ltd. The current obv is 905,210.

SomnoMed Ltd Daily On-Balance Volume (OBV) ChartSomnoMed Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SomnoMed Ltd. The current mfi is 86.18.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
SomnoMed Ltd Daily Money Flow Index (MFI) ChartSomnoMed Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SomnoMed Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

SomnoMed Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SomnoMed Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.709
Ma 20Greater thanMa 500.372
Ma 50Greater thanMa 1000.348
Ma 100Greater thanMa 2000.293
OpenGreater thanClose0.430
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Somnomed with someone you think should read this too:
  • Are you bullish or bearish on Somnomed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Somnomed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SomnoMed Ltd

I send you an email if I find something interesting about SomnoMed Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about SomnoMed Ltd.

Receive notifications about SomnoMed Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.